A Study to Evaluate Non-significant Risk Operation Magnetic Resonance Imaging for MRI Guided Ablation
Launched by MAYO CLINIC · May 7, 2021
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new technology called iMRI, which stands for intraoperative Magnetic Resonance Imaging. The goal is to see if this technology can help doctors get better images and faster information during certain procedures. By evaluating how well this technology works, the researchers hope to improve patient care in the future.
If you or someone you know is between 18 and 74 years old and is in good health, you might be eligible to participate. The study is open to both healthy volunteers and patients who are already scheduled for a procedure that uses MR-guided imaging. Participants can expect to help researchers understand how this new technology can benefit future medical procedures. It's important to note that pregnant women and individuals under 18 cannot participate in this study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male or female.
- • Age ≥ 18 years.
- • Healthy volunteers or patients already scheduled for a MR-guided procedure.
- Exclusion Criteria:
- • Individuals 18 years of age.
- • Pregnant women.
About Mayo Clinic
Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, Minnesota, United States
Patients applied
Trial Officials
Aiming Lu, PhD
Principal Investigator
Mayo Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials